Cargando…
Precision Oncology in Canada: Converting Vision to Reality with Lessons from International Programs
Canada’s healthcare system, like others worldwide, is immersed in a process of evolution, attempting to adapt conventional frameworks of health technology assessment (HTA) and funding models to a new landscape of precision medicine in oncology. In particular, the need for real-world evidence in Cana...
Autores principales: | Liu, Geoffrey, Cheung, Winson Y., Feilotter, Harriet, Manthorne, Jackie, Stockley, Tracy, Yeung, ManTek, Renouf, Daniel J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9600134/ https://www.ncbi.nlm.nih.gov/pubmed/36290849 http://dx.doi.org/10.3390/curroncol29100572 |
Ejemplares similares
-
Engineering a DNA damage response without DNA damage
por: Yeung, ManTek, et al.
Publicado: (2008) -
Estimating the Impact of Delayed Access to Oncology Drugs on Patient Outcomes in Canada
por: Vanderpuye-Orgle, Jackie, et al.
Publicado: (2022) -
A Comparison of Patients’ and Physicians’ Knowledge and Expectations Regarding Precision Oncology Tests
por: Dehar, Navdeep, et al.
Publicado: (2022) -
Future Role of Health Technology Assessment for Genomic Medicine in Oncology: A Canadian Laboratory Perspective
por: Husereau, Don, et al.
Publicado: (2023) -
Building infrastructure for outcomes-based agreements in Canada: can administrative health data be used to support an outcomes-based agreement in oncology?
por: Cheung, Winson Y., et al.
Publicado: (2022)